share_log
Reuters ·  Dec 19, 2024 19:47
Humacyte Announces FDA Approval of Symvess™ (Acellular Tissue Engineered Vessel-Tyod) for the Treatment of Extremity Vascular Trauma
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment